Nexo Therapeutics’ $60 Million Series A Financing Round

Wilson Sonsini Goodrich & Rosati advised Versant Ventures and New Enterprise Associates on the deal.Nexo Therapeutics (Nexo) announced it has emerged from stealth with $60 million Series…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now